Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2013
10/24/2013US20130281539 Highly Selective 5-HT(2C) Receptor Agonists That Show Anti-Psychotic Effects with Antagonist Activity at the 5-HT(2B) Receptor
10/24/2013US20130281537 Aqueous liquid bromfenac composition having preservative efficacy
10/24/2013US20130281536 3,5,3'-Triiodothyronine Sulfate As Thyromimetic Agent And Pharmaceutical Formulations Thereof
10/24/2013US20130281535 Lipid-lowering antidiabetic agent
10/24/2013US20130281534 Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
10/24/2013US20130281533 Pet Food Compositions and Methods for Weight Loss and Matinenance
10/24/2013US20130281532 Compositions for topical treatment of microbial infections
10/24/2013US20130281530 Methods of therapeutic monitoring of phenylacetic acid prodrugs
10/24/2013US20130281529 Eye drop preparation comprising latanoprost
10/24/2013US20130281528 Method of treating gastric cancer
10/24/2013US20130281527 Polyphenol Extraction Process
10/24/2013US20130281526 Method for treating irritable bowel syndrome with diarrhea
10/24/2013US20130281524 Novel treatments
10/24/2013US20130281523 Low dose cannabinoid medicaments
10/24/2013US20130281522 Methods for alzheimer's disease treatment and cognitive enhancement
10/24/2013US20130281520 Anti-Inflammatory And Antioxidant Conjugates Useful For Treating Metabolic Disorders
10/24/2013US20130281517 Cyclopropanecarboxylate esters of purine analogues
10/24/2013US20130281515 Cationic bis-urea compounds as effective antimicrobial agents
10/24/2013US20130281514 Targeting glioma stem cells by sequence-specific functional inhibition of pro-survival oncomir-138
10/24/2013US20130281513 siRNA FOR INHIBITION OF Hif1alpha EXPRESSION AND ANTICANCER COMPOSITION CONTAINING THE SAME
10/24/2013US20130281512 Agents for treating disorders involving modulation of ryanodine receptors
10/24/2013US20130281509 Antisense modulation of fibroblast growth factor receptor 4 expression
10/24/2013US20130281508 MicroRNA target site for cell- or tissue-specific inhibition of expression of a transgene
10/24/2013US20130281506 Combination of a non-steroidal anti-inflammatory drug with an anti-histaminic drug intended for ophthalmic use
10/24/2013US20130281504 Reduction of Microglia-Mediated Neurotoxicity by KCa3.1 Inhibition
10/24/2013US20130281501 Topical localized isoxazoline formulation
10/24/2013US20130281498 Aminothiazole modulators of beta-3-adrenoreceptor
10/24/2013US20130281497 Macrocyclic compounds and methods of treatment
10/24/2013US20130281493 Method for Treating Cancer Harboring a p53 Mutation
10/24/2013US20130281491 Formulations and delivery
10/24/2013US20130281487 Solid Forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
10/24/2013US20130281484 HDAC Inhibitors and Therapeutic Methods of Using Same
10/24/2013US20130281482 Nicotinic acetylcholine receptor agonists
10/24/2013US20130281481 Sublingual and buccal film compositions
10/24/2013US20130281480 Oral Drug Delivery System
10/24/2013US20130281479 Sustained release monoeximic formulations of opioid and nonopioid analgesics
10/24/2013US20130281478 Combination of syrosingopine and mitochondrial inhibitors for the treatment of cancer and immunosuppression
10/24/2013US20130281477 Hydrochloride salts of 8-[1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diazaspiro[4,5]decan-2-one and preparation process therefor
10/24/2013US20130281472 Composition and method for treating or preventing skeletal muscle fibrosis
10/24/2013US20130281471 Acyclovir Formulations
10/24/2013US20130281470 Use of (R)-Penciclovir Triphosphate for the Manufacture of a Medicament for the Treatment of Viral Diseases
10/24/2013US20130281469 Thioacetate compounds, compositions and methods of use
10/24/2013US20130281465 Pyrazole derivative
10/24/2013US20130281463 Diaza-spiro[5.5]undecanes useful as orexin receptor antagonists
10/24/2013US20130281454 Prostaglandin and vasoconstrictor pharmaceutical compositions and methods of use
10/24/2013US20130281450 Isoindolone derivatives
10/24/2013US20130281449 Oxazine Derivatives and their Use in the Treatment of Neurological Disorders
10/24/2013US20130281447 Jnk inhibitors for the treatment of endometriosis
10/24/2013US20130281446 Xinafoate salt of n4-(2,2-difluoro-4h-benzo[1,4]oxazin-3-one)-6-yl]-5-fluoro-n2-[3-(methylaminocarbonylmethyleneoxy)phenyl]2,4-pyrimidinediamine
10/24/2013US20130281445 Compounds useful as inhibitors of choline kinase
10/24/2013US20130281444 Preparation and pharmaceuticals of biphenyl benzamide-derived derivatives
10/24/2013US20130281437 Method for cancer therapy
10/24/2013US20130281436 Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia
10/24/2013US20130281435 Therapeutic agent for irritable bowel syndrome
10/24/2013US20130281434 Therapeutic compounds
10/24/2013US20130281433 Therapeutic compounds
10/24/2013US20130281432 Pyridinones/pyrazinones, method of making, and method of use thereof
10/24/2013US20130281430 Amino-Indolyl-Substituted Imidazolyl-Pyrimidines and Their Use as Medicaments
10/24/2013US20130281429 2,4-diamino-pyrimidines as aurora inhibitors
10/24/2013US20130281423 Methods and compositions for ameliorating pancreatic cancer
10/24/2013US20130281422 Treatment of Pain Associated with Dislocation of Basal Endometrium
10/24/2013US20130281420 Ophthalmic Formulations of Squalamine
10/24/2013US20130281419 Therapeutic Uses for an Aminosterol Compound
10/24/2013US20130281418 Use of hydroxypregnenolone derivatives for enhancing health and physical performance
10/24/2013US20130281417 Implants and methods for treating inflammation-mediated conditions of the eye
10/24/2013US20130281416 Pharmaceutical composition
10/24/2013US20130281415 NEW CYCLOHEXYLAMINE DERIVATIVES HAVING ß2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES
10/24/2013US20130281414 Thiazolidinedione analogues
10/24/2013US20130281412 Pharmaceutical composition of salicylanilide-derived small molecules and preparation and application thereof
10/24/2013US20130281411 Compositions for treating inflammatory dermatological diseases and conditions and methods of use thereof
10/24/2013US20130281410 Methods for the treatment of psychiatric disorders
10/24/2013US20130281409 Myelin Sheath Fatty Acids that Resolve Neuroinflammation
10/24/2013US20130281408 Combination of an hmg-coa reductase inhibitor and a farnesyl-pyrophosphatase synthase inhibitor for the treatment of diseases related to the persistence and/or accumulation of prenylated proteins
10/24/2013US20130281406 Thiazole derivatives and their use as p2y12 receptor antagonists
10/24/2013US20130281405 Use of pc-nsaids to treat and/or prevent pulmonary inflammation
10/24/2013US20130281404 Composition containing 2-acyl-lysophosphatidylserine and method for producing the same
10/24/2013US20130281403 Compounds and compositions for the treatment of parasitic diseases
10/24/2013US20130281402 Hdac inhibiting derivatives of camptothecin
10/24/2013US20130281401 Combination therapy for the treatment of depression and other non-infectious diseases
10/24/2013US20130281399 Treatment of diseases by epigenetic regulation
10/24/2013US20130281398 Treatment of diseases by epigenetic regulation
10/24/2013US20130281397 Treatment of diseases by epigenetic regulation
10/24/2013US20130281396 Treatment of diseases by epigenetic regulation
10/24/2013US20130281395 Novel tlr4 inhibitors for the treatment of human infectious and inflammatory disorders
10/24/2013US20130281394 Chemosensory Receptor Ligand-Based Therapies
10/24/2013US20130281392 Parasiticidal compositions comprising benzimidazole derivatives, methods and uses thereof
10/24/2013US20130281390 Method for treating dry eye
10/24/2013US20130281389 Novel drug targets to overcome de novo drug-resistance in multiple myeloma
10/24/2013US20130281388 Opioid agonist antagonist combinations
10/24/2013US20130281387 Chemosensory Receptor Ligand-Based Therapies
10/24/2013US20130281386 Glufosfamide Combination Therapies for Cancer
10/24/2013US20130281381 Pharmaceutical compositions comprising 8-substituted dibenzylbutyrolactone lignans
10/24/2013US20130281373 Combination therapy
10/24/2013US20130281372 Methods to enhance rnai oligonucleotide delivery to respiratory epithelial cells
10/24/2013US20130281366 Heterocyclic compounds suitable for the treatment of dyslipidemia
10/24/2013US20130281365 Fused aromatic ptp-1b inhibitors
10/24/2013US20130281362 Antiviral agent
10/24/2013US20130281359 New bicyclic compounds and their use as antibacterial agents and beta-lactamase inhibitors
10/24/2013US20130280343 Food Products Derived From Cannabinoid-Administered Livestock
10/24/2013US20130280340 Compositions and methods of using lamellar bodies for modifying linear biological macromolecules
1 ... 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 ... 7860